|
|
 | | | |
- close
- close
- close
- close
Emeritus Corporation (ESC) |
QUOTE AND NEWS
StreetInsider.com
May 3
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Emeritus+%28ESC%29+Reports+Q1+FFO+of+%240.38%3B+Guides+FY12/7402181.html for the full story.
Business Wire
May 3
Comment
Emeritus Corporation (NYSE: ESC), a national provider of senior living services, today announced its first quarter 2012 results. Operating Summary for First Quarter 2012 Compared to First Quarter 2011 Total revenues increased $22.8 million, or 7.6%,
Business Wire
Apr 19
Comment
Emeritus Corporation (NYSE: ESC), a national provider of senior living services, today announced that management will host a conference call on Thursday, May 3, 2012, at 5:00 P.M. Eastern Time to discuss its financial results for the first quarter of
PR Newswire
Apr 13
Comment
Impact: 3,700,000 Chicago area men, women, children, and families CHICAGO, April 13, 2012 /PRNewswire-USNewswire/ -- In recognition of National Volunteer Week, April 15-21, Executive Service Corps (ESC) released volunteer figures for its professional
PR Newswire
Mar 28
Comment
SEATTLE, March 28, 2012 /PRNewswire/ -- Non-profit organization 3in4 Association and its spokesperson, elder care expert & author Dr. Marion, today announced a partnership with Emeritus Senior Living, a leading national provider of senior living
PR Newswire
Mar 23
Comment
SAN JOSE, Calif., March 23, 2012 /PRNewswire/ -- Atmel®( )Corporation (NASDAQ: ATML), a leader in microcontroller and touch solutions, today announced that it will be exhibiting a variety of its microcontroller (MCU) and embedded solutions at ESC
Benzinga
Mar 7
Comment
Stifel Nicolaus cuts its price target $3 to $22 on Buy-rated Emeritus Corporation (NYSE: ESC) following the company's quarterly earnings miss.
Stifel Nicolaus says, "With an earnings miss we wouldn't be surprised to see shares lower on...
Benzinga
Feb 27
Comment
Morgan Keegan reiterates its Outperform rating and $21 target price on Emeritus Corporation (NYSE: ESC) ahead of the company's Q4 earnings next Tuesday.
Morgan Keegan says, "Investors are concerned about occupancy and rate trends. We expect...
FierceBiotech
Jan 23
Comment
The beleaguered embryonic stem cell field got a boost today from a clinical trial sample in which two legally blind patients demonstrated partially restored vision after getting an injection of new cells prepared by Advanced Cell Technology...
StreetInsider.com
Jan 3
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Management+Changes/Emeritus+Corporation+%28ESC%29+Names+Mark+A.+Finkelstein+Executive+VP+of+Corporate+Development+and+General+Counsel./7050798.html for the full story.
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| |||||||
